Increased Incidence of Villitis in Placentas Exposed to Chemotherapy During Pregnancy: Is There a Correlation?

Abstract

We have identified 9 pregnant patients who were diagnosed with malignancy and initiated chemotherapy during their second trimester (cervical cancer [n = 3], leukemia [n = 3], breast cancer [n = 2], and Hodgkin’s lymphoma [n = 1]). Five of the patients’ placentas were small for gestational age (SGA). Pathologic examination revealed inflammatory changes in 4 of the placentas: 2 from the SGA placentas and 2 from non-SGA placentas. Examination revealed 3 placentas with villitis of unknown etiology (VUE) and 1 with intervillositis; all were negative for bacterial and viral cultures and by immunohistochemical (IHC) stains. In the VUE cases, IHC stains showed positivity of CD25+/FOXP3+ with focal positivity and CD3 and CD4 IHC were focally to strongly positive. Literature suggests that the use of chemotherapy during pregnancy can be detrimental to both the mother and the fetus; however, there has been limited focus on the effects of chemotherapy on the placenta. We suggest that the inflammatory process noted in the placentas is due to chemotherapy-induced toxic effects.

Keywords

chemotherapy danger model FOXP3 immunohistochemistry placenta small for gestational age villitis of unknown etiology

Get full access to this article

View all access options for this article.

References

Abellar

Pepperell

Greco

, et al. Effects of chemotherapy during pregnancy on the placenta. Pediatr Dev Pathol 2009; 12: 35–41.

Cardonick

Iacobucci

. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283–291.

FDA. Proposed Rules, Silver Spring, MD: FDA, 2008.

Leslie

. Chemotherapy and pregnancy. Clin Obstet Gynecol 2002; 45: 153–164.

Antonelli

Dotters

Katz

Kuller

. Cancer in pregnancy: a review of the literature. Part I and II. Obstet Gynecol Surv 1996; 51: 125–142.

Potter

Schoeneman

. Metastasis of maternal cancer to the placenta and fetus. Cancer 1970; 25: 380–388.

Mor

Cardenas

. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63: 425–433.

Bonney

. Immune regulation in pregnancy: a matter of perspective? Obstet Gynecol Clin North Am 2016; 43: 679–698.

Matzinger

. The danger model: a renewed sense of self. Science 2002; 296: 301–305.

10.

Mor

. Inflammation and pregnancy: the role of toll-like receptors in trophoblast-immune interaction. Ann N Y Acad Sci 2008; 1127: 121–128.

11.

Zemlickis

Lishner

Degendorfer

Panzarella

Sutcliffe

Koren

. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 1992; 152: 573–576.

12.

Amant

Van Calsteren

Halaska

, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 2012; 13: 256–264.

13.

Aviles

Diaz-Maqueo

Talavera

Guzman

Garcia

. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991; 36: 243–248.

14.

Aviles

Niz

. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 1988; 16: 3–6.

15.

Kurbacher

Cree

, et al. Chemosensitivity of normal human trophoblasts evaluated by a newly developed ATP-based luminescence assay. Anticancer Drugs 2002; 13: 701–708.

16.

Matalon

Ornoy

Fishman

Drucker

Lishner

. The effect of 6-mercaptopurine on early human placental explants. Hum Reprod 2005; 20: 1390–1397.

17.

Redline

Patterson

. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993; 143: 473–479.

18.

Tamblyn

Lissauer

Powell

Cox

Kilby

. The immunological basis of villitis of unknown etiology—review. Placenta 2013; 34: 846–855.

19.

Katzman

Murphy

Oble

. Immunohistochemical analysis reveals an influx of regulatory T cells and focal trophoblastic STAT-1 phosphorylation in chronic villitis of unknown etiology. Pediatr Dev Pathol 2011; 14: 284–293.